|
Bailey S, Ferraresso M, Alonso-Crisostomo L, Ward D, Smith S, Nicholson JC,... |
Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters... |
Tuesday, October 3, 2023 |
Br J Cancer |
|
Bailey S, Murray MJ, Witkowski L, Hook E, Hasselblatt M, Crawford R, et al. |
Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, h... |
Tuesday, October 14, 2014 |
Pediatric blood & cancer |
|
Bain LK, Myint PK, Jennings A, Lentjes MA, Luben RN, Khaw KT, et al. |
The relationship between dietary magnesium intake, stroke and its major ris... |
Thursday, June 18, 2015 |
International journal of cardiology |
|
Baiocchi GL, D'Ugo D, Coit D, Hardwick R, Kassab P, Nashimoto A, et al... |
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Con... |
Sunday, July 5, 2015 |
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association |
|
Baird, R. D., Linossi, C., Middleton, M., Lord, S., Harris, A., Rodon, J., ... |
First-in-human Phase I study of MP0250, a First-in-class DARPIN Drug Candid... |
Thursday, December 10, 2020 |
Journal of Clinical Oncology |
|
Balasooriya-Smeekens C, Walter FM, Scott S |
The role of emotions in time to presentation for symptoms suggestive of can... |
Wednesday, May 20, 2015 |
Psycho-oncology |
|
Balmus G, Karp NA, Ng BL, Jackson SP, Adams DJ, McIntyre RE |
A high-throughput in vivo micronucleus assay for genome instability screeni... |
Thursday, January 1, 2015 |
Nature protocols |
|
Balmus G, Larrieu D, Barros AC, Collins C, Abrudan M, Demir M, Geisler NJ, ... |
Targeting of NAT10 enhances healthspan in a mouse model of human accelerate... |
Friday, April 27, 2018 |
Nature Communications |
|
Bamia C, Lagiou P, Jenab M, Aleksandrova K, Fedirko V, Trichopoulos D, et a... |
Fruit and vegetable consumption in relation to hepatocellular carcinoma in ... |
Friday, March 6, 2015 |
British journal of cancer |
|
Banerjee S, Michalarea V, Ang JE, Ingles Garces A, Biondo A, Funingana IG, ... |
Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Syn... |
Tuesday, November 1, 2022 |
Clinical Cancer Research |
